李春红副教授-硕导
作者:  发布时间:19-03-28 14:34:58   浏览次数: 次   来源:

 

 

 

 

李春红(1982.02~),女,药剂学博士,副研究员,西南医科大学药剂学教研室,lispringhong@126.com

研究方向:

1. 靶向药物制剂研究;

2. 药物新剂型与新制剂的研究。

教育经历:

20132016年:四川大学华西药学院药剂学博士研究生;

20082010年:泸州医学院药理学硕士研究生;

20012005年:泸州医学院药学本科。

主持及参研的科研项目:

1. 国家自然科学基金青年基金,基于巨噬细胞极化靶向治疗类风湿性关节炎的仿生纳米递药系统研究,2019.01-2021.1220万元,在研,主持;

2.四川省科技厅创新苗子工程项目,2017RZ0048,一种主动靶向类风湿关节炎的外排体载药系统的构建及抗关节炎作用研究,2017.03-2020.0310万元,在研,主持;

3.四川省卫生和计划生育委员会重点项目,肿瘤靶向肽介导的主动靶向纳米递药系统的构建及抗乳腺癌研究,2019.01-2021.122万元,在研,主持;

4. 西南医科大学青年基金项目,148pH敏感的纳米给药系统靶向治疗类风湿关节炎的研究,2017/01-2019/121万元,在研,主持;

5. 西南医科大学青年基金项目,128,酶敏感PEG-地塞米松壳-核胶束靶向治疗肺癌的研究,2016/01-2018/121万元,在研,主持;

6. 泸州市-医学院联合基金,2013LZLY-K61,青果、山银花及栀子有效成分的提取纯化及其靶向纳米脂质超声微泡的研制,2014/01-2016/1210万元,已结题,参加;

7. 泸州市-医学院联合基金,2013LZLY-K70,双青咽喉片的成型工艺研究及安全性评价,2014/01-2016/1210万元,已结题,参加;

8. 四川省教育厅重大培育项目,12ZZ013,复尔康多相脂质体抗肿瘤作用及产品开发研究,2012/01-2015/125万元,已结题,参加。

代表性论著:

1. Xiaoduan Sun, Jun Wei, Jiayao Lyu, Tierong Bian, Zhongbing Liu, Juan Huang, Fengjuan Pi, Chunhong Li*, Zhirong Zhong*.Bone-targeting drug delivery system of biomineral-binding liposomes loaded with icariin enhances the treatment for osteoporosis, Journal of Nanobiotechnology, 2019, 17(10): 2-16. (通讯作者,IF=5.294

2. Yan Lin, Chunhong Li, Jian Li, Ruolan Deng, Juan Huang, Qinglian Zhang, Jiayao Lyu, Na Hao*, Zhirong Zhong*.NEP1-40-modified human serum albumin nanoparticles enhance the therapeutic effect of methylprednisolone against spinal cord injury, Journal of Nanobiotechnology, 2019, 17(12): 2-15. (第一作者,IF=5.294

3. Chunhong Li, Hanmei Li, Qin Wang, Meiling Zhou, Man Li, Tao Gong, Zhirong Zhang, Xun Sun*, pH-Sensitive polymeric micelles for targeted delivery to inflamed joints, Journal of controlled release, 2017, 246:133-141. (第一作者,IF=7.786

4. Meiling Zhou#, Jierong Hou#, Zhirong Zhong, Na Hao, Yan Lin, Chunhong Li*, Targeted delivery of hyaluronic acid-coated solid lipid nanoparticles for rheumatoid arthritis therapy, Drug delivery, 2018, 25(1): 716-722. (通讯作者,IF=3.095

5. Shuangli Xiao#, Zhongbing Liu#, Ruolan Deng#, Chunhong Li , Shaozhi Fu, Guilan Chen, Xiaoqin Zhang, Famin Ke, Siyun Ke, Xin Yu, Shurong Wang, Zhirong Zhong*, Aptamer-mediated gene therapy enhanced antitumor activity against human hepatocellular carcinoma in vitro and in vivo, Journal of controlled release, 2017, 258: 130-145. (第二作者,IF=7.786

6.Yunlong Wang#, Yuling Luo#, Chunhong Li, Xiaoqin Zhang, Chao Pi, Lu Yu. Shurong Wang, Zhirong Zhong*, Optimized formulation of multivesicular liposomes loaded with oleanolic acid enhanced anticancer effect in vitro, Drug design development and therapy, 2017, 11: 955-968. (第二作者,IF=2.822

7.Li Liu, Famin Ke, Chunhong Li, Xiaoqin Zhang, Chao Pi, Li Wang, Siyun Ke, Yuling Luo, Zhirong Zhong*, Multivesicular liposomes loading with ursolic Acid enhanced the in vitro antitumor activity on hepatic carcinoma cells, Latin American journal of pharmacy, 2017, 36(4): 758-766. (第三作者,IF=0.298

8. Meiling Zhou, Jianbo Li, Chunhong Li, Ling Guo, Xinyi Wang, Qin He, Yao Fu*, Zhirong Zhang*, Tertiary amine mediated targeted therapy against metastatic lung cancer, Journal of controlled release, 2016, 241:81- 93. (第三作者,IF=7.786

 

>>更多
工作动态
  • 药学院开展“践行社会主义核心价值观,争做四有教师...[详细]
  • 药学院安排布置新学期工作[详细]
  • 科技处一行到药学院开展调研座谈活动[详细]
  • 药学院举办本学期首次学生政工干部专题培训会[详细]